Page last updated: 2024-08-24

topotecan and 103d5r

topotecan has been researched along with 103d5r in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belozerov, VE; Van Meir, EG1

Reviews

1 review(s) available for topotecan and 103d5r

ArticleYear
Hypoxia inducible factor-1: a novel target for cancer therapy.
    Anti-cancer drugs, 2005, Volume: 16, Issue:9

    Topics: Benzopyrans; Cell Hypoxia; Heterocyclic Compounds, 4 or More Rings; Humans; Hypoxia-Inducible Factor 1; Microtubules; Models, Biological; Mustard Compounds; Neoplasms; Phenylpropionates; Phosphoinositide-3 Kinase Inhibitors; Signal Transduction; Sirolimus; Topotecan; Tubulin Modulators

2005